Pressure Biosciences, Inc. (PBIO) Posts Recognized Revenue Increases
Pressure Biosciences (NASDAQ: PBIO) recently announced its September 2007 quarter highlights for the period ended September 30, 2007. The company posted revenue of $138,052, as compared to $92,211 for the same period in 2006. Revenue from the sale of the company’s Pressure Cycling Technology (PCT) sample preparation products and services was $106,787; up from $92,211 from the same period last year. The increase in revenue is attributed to increased installations of PCTs, which rose to eight installations in the 2007 quarter, as compared to three for the same period of 2006. The company also sold two Barocycler NEP3229s, four Barocycler…